What's Going On With Esperion Stock Tuesday? - Esperion Therapeutics (NASDAQ:ESPR)

Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares are down during Tuesday’s premarket session as the company announced a definitive agreement to acquire Corstasis Therapeutics.This news comes as broader markets experienced declines, with major indices like the S&P 500 and Nasdaq both closing lower on the previous trading day.Esperion has entered into an agreement to acquire Corstasis, which developed Enbumyst, the first FDA-approved nasal spray diuretic for treating edema associated with congestive heart fai ...